Last reviewed · How we verify
Plasmodium Falciparum Malaria Prevention
Approved treatments
- Hydroxychloroquine Sulfate · Sanofi
Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases. - Aralen · Sanofi
Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death. - Hydroxychloroquine Sulfate · Advanz
Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body. - Malarone · GSK
Malarone works by inhibiting the parasite's ability to synthesize nucleic acids, ultimately preventing its replication and spread within the body. - Mepron
Mepron works by inhibiting the electron transport chain in the mitochondria of Plasmodium parasites, ultimately leading to their death. - Hydroxychloroquin · Children's Hospital of Fudan University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Plasmodium Falciparum Malaria Prevention patent landscape — cliff calendar, originator estates, attackable patents
- Plasmodium Falciparum Malaria Prevention treatment landscape brief
- Plasmodium Falciparum Malaria Prevention treatment updates RSS
Frequently asked questions about Plasmodium Falciparum Malaria Prevention
What drugs treat Plasmodium Falciparum Malaria Prevention?
Tracked treatments include Hydroxychloroquine Sulfate, Aralen, Malarone, Mepron, Hydroxychloroquin.
What is the treatment for Plasmodium Falciparum Malaria Prevention?
Standard treatment for Plasmodium Falciparum Malaria Prevention includes Hydroxychloroquine Sulfate, Aralen, Malarone, Mepron, Hydroxychloroquin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Plasmodium Falciparum Malaria Prevention patent cliff · Plasmodium Falciparum Malaria Prevention CI report
- Treatment: Hydroxychloroquine Sulfate · Sanofi
- Treatment: Aralen · Sanofi
- Treatment: Hydroxychloroquine Sulfate · Advanz
- Treatment: Malarone · GSK
- Treatment: Mepron
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing